المؤلفون: van Dam, JL, Verkolf, EMM, Dekker, EN, Bonsing, BA, Bratlie, SO, Brosens, LAA, Busch, OR, van Driel, LMJW, van Eijck, CHJ, Feshtali, S, Ghorbani, P, de Groot, DJA, de Groot, JWB, Haberkorn, BCM, de Hingh, IH, van der Holt, B, Karsten, TM, van der Kolk, MB, Labori, KJ, Liem, MSL, Loosveld, OJL, Molenaar, IQ, Polee, MB, van Santvoort, HC, Geelen, JD, Wumkes, ML, van Tienhoven, G, Homs, MYV, Besselink, MG, Wilmink, JW, Koerkamp, BG

المصدر: BMC cancer. 23(1):728

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:153462909

المؤلفون: Haberkorn BCM; Department of Medical Oncology, Maasstad Ziekenhuis Rotterdam, Maasstadweg 21, 3079 DZ, Rotterdam, the Netherlands. Haberkornb@maasstadziekenhuis.nl., Hoogendijk L; VUMC, Amsterdam, Netherlands., Loosveld OS; Department of Medical Oncology, Amphia Ziekenhuis Breda, Breda, Netherlands., Thijs AMJ; Department of Medical Oncology, Catharina Ziekenhuis Eindhoven, Eindhoven, Netherlands., Verstijnen J; Department of Medical Oncology, Maasstad Ziekenhuis Rotterdam, Maasstadweg 21, 3079 DZ, Rotterdam, the Netherlands.

المصدر: Journal of gastrointestinal cancer [J Gastrointest Cancer] 2024 Jun; Vol. 55 (2), pp. 838-844. Date of Electronic Publication: 2024 Feb 06.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Springer Science+Business Media Country of Publication: United States NLM ID: 101479627 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1941-6636 (Electronic) NLM ISO Abbreviation: J Gastrointest Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Pancreatic Neoplasms*/drug therapy , Pancreatic Neoplasms*/pathology , Pancreatic Neoplasms*/mortality , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Leucovorin*/therapeutic use , Leucovorin*/adverse effects , Irinotecan*/therapeutic use , Fluorouracil*/therapeutic use , Oxaliplatin*/therapeutic use , Oxaliplatin*/administration & dosage , Hospitals, General*/statistics & numerical data, Humans ; Male ; Female ; Netherlands/epidemiology ; Retrospective Studies ; Middle Aged ; Aged ; Treatment Outcome ; Quality of Life ; Neoplasm Metastasis

عنوان ترانسليتريتد: Hoe lang zijn patiënten bereid te reizen voor medisch-oncologische zorg?

المؤلفون: de Boer ECS; Isala, afd. Isala Oncologisch centrum, Zwolle., Versluis MAJ; Integraal Kankercentrum Nederland, afd. Research and Development, Utrecht., Vissers PAJ; Integraal Kankercentrum Nederland, afd. Research and Development, Utrecht., Slingerland M; Leids Universitair Medisch Centrum, afd. Medische Oncologie, Leiden., Haberkorn BCM; Maasstad ziekenhuis, afd. Interne Geneeskunde, Rotterdam., de Ruiter MB; Nederlandse Federatie van Kankerpatiëntenorganisaties, Utrecht., Dingemans IH; Nederlandse Federatie van Kankerpatiëntenorganisaties, Utrecht., van de Poll-Franse LV; Integraal Kankercentrum Nederland, afd. Research and Development, Utrecht., Reyners AKL; UMC Groningen, afd. Medische Oncologie, Groningen., Wymenga ANM; Medisch Spectrum Twente, afd. Interne Geneeskunde, Enschede.; Contact: A. N.M. Wymenga (a.wymenga@mst.nl).

المصدر: Nederlands tijdschrift voor geneeskunde [Ned Tijdschr Geneeskd] 2023 Dec 12; Vol. 167. Date of Electronic Publication: 2023 Dec 12.

نوع المنشور: English Abstract; Journal Article

بيانات الدورية: Publisher: Vereniging NTvG Country of Publication: Netherlands NLM ID: 0400770 Publication Model: Electronic Cited Medium: Internet ISSN: 1876-8784 (Electronic) Linking ISSN: 00282162 NLM ISO Abbreviation: Ned Tijdschr Geneeskd Subsets: MEDLINE

مواضيع طبية MeSH: Medical Oncology* , Neoplasms*/therapy, Humans ; Netherlands ; Patients ; Ethnicity

المؤلفون: Isebia KT; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands., Mostert B; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands., Deger T; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands., Kraan J; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands., de Weerd V; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands., Oomen-de Hoop E; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands., Hamberg P; Department of Internal Medicine, Franciscus Gasthuis & Vlietland, Rotterdam/Schiedam, The Netherlands., Haberkorn BCM; Department of Medical Oncology, Maasstad Hospital, Rotterdam, The Netherlands., Helgason HH; Department of Medical Oncology, Haaglanden Medical Centre, The Hague, The Netherlands., de Wit R; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands., Lolkema MP; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands., Wilting SM; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands., van Riet J; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands., Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands.

المصدر: Molecular oncology [Mol Oncol] 2023 Sep; Vol. 17 (9), pp. 1898-1907. Date of Electronic Publication: 2023 Aug 18.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Prostatic Neoplasms, Castration-Resistant*/diagnosis , Prostatic Neoplasms, Castration-Resistant*/genetics , Prostatic Neoplasms, Castration-Resistant*/drug therapy , Neoplastic Cells, Circulating*/pathology , Circulating Tumor DNA*/genetics, Male ; Humans ; Prognosis ; Biomarkers, Tumor/genetics ; Aneuploidy

المؤلفون: Bond MJG; Department of Epidemiology, Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht University, Utrecht, Netherlands., Bolhuis K; Department of Gastrointestinal Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Medical Oncology, Cancer Centre Amsterdam, Amsterdam University Medical Centre, University of Amsterdam, Netherlands., Loosveld OJL; Department of Medical Oncology, Amphia Hospital, Breda, Netherlands., de Groot JWB; Department of Medical Oncology, Isala Oncology Centre, Zwolle, Netherlands., Droogendijk H; Department of Internal Medicine, Bravis Hospital, Roosendaal, Netherlands., Helgason HH; Department of Medical Oncology, Haaglanden Medical Centre, The Hague, Netherlands., Hendriks MP; Department of Medical Oncology, Northwest Clinics, Alkmaar, Netherlands., Klaase JM; Department of Hepatobiliary Surgery and Liver Transplantation, University Medical Centre Groningen, Groningen, Netherlands., Kazemier G; Department of Surgery, Amsterdam UMC, location Vrije Universiteit, Amsterdam, Netherlands; Cancer Center Amsterdam, Amsterdam, Netherlands., Liem MSL; Department of Surgery, Medisch Spectrum Twente, Enschede, Netherlands., Rijken AM; Department of Surgery, Amphia Hospital, Breda, Netherlands., Verhoef C; Department of Surgery, Erasmus Medical Centre Cancer Institute, Rotterdam, Netherlands., de Wilt JHW; Department of Surgery, Radboud University Medical Centre, Nijmegen, Netherlands., de Jong KP; Department of Hepatobiliary Surgery and Liver Transplantation, University Medical Centre Groningen, Groningen, Netherlands., Gerhards MF; Department of Surgery, OLVG Hospital, Amsterdam, Netherlands., van Amerongen MJ; Department of Radiology, Sint Maartenskliniek, Nijmegen, Netherlands., Engelbrecht MRW; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centre, University of Amsterdam, Netherlands., van Lienden KP; Department of Radiology, Sint Antonius Hospital, Nieuwegein, Netherlands., Molenaar IQ; Department of Surgery, University Medical Centre Utrecht, Utrecht University, Utrecht, Netherlands., de Valk B; Department of Medical Oncology, Spaarne Gasthuis, Hoofddorp, Netherlands., Haberkorn BCM; Department of Medical Oncology, Maasstad Hospital, Rotterdam, Netherlands., Kerver ED; Department of Medical Oncology, OLVG Hospital, Amsterdam, Netherlands., Erdkamp F; Department of Medical Oncology, Zuyderland Medical Centre, Heerlen, Netherlands., van Alphen RJ; Department of Medical Oncology, Elisabeth-TweeSteden Hospital, Tilburg, Netherlands., Mathijssen-van Stein D; Department of Medical Oncology, Franciscus Gasthuis & Vlietland, Rotterdam, Netherlands., Komurcu A; The Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands., Lopez-Yurda M; Biometrics Department, The Netherlands Cancer Institute, Amsterdam, Netherlands., Swijnenburg RJ; Department of Surgery, Amsterdam University Medical Centre, University of Amsterdam and Vrije Universiteit Amsterdam, Amsterdam, Netherlands; Cancer Center Amsterdam, Amsterdam, Netherlands., Punt CJA; Department of Epidemiology, Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht University, Utrecht, Netherlands; Department of Medical Oncology, Cancer Centre Amsterdam, Amsterdam University Medical Centre, University of Amsterdam, Netherlands. Electronic address: c.j.a.punt@umcutrecht.nl.

مؤلفون مشاركون: Dutch Colorectal Cancer Study Group

المصدر: The Lancet. Oncology [Lancet Oncol] 2023 Jul; Vol. 24 (7), pp. 757-771. Date of Electronic Publication: 2023 Jun 14.

نوع المنشور: Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Colorectal Neoplasms*/drug therapy , Colorectal Neoplasms*/genetics , Colorectal Neoplasms*/pathology , Liver Neoplasms*/drug therapy , Liver Neoplasms*/genetics , Liver Neoplasms*/secondary , Hypertension*/chemically induced , Neutropenia*/chemically induced, Humans ; Male ; Female ; Middle Aged ; Bevacizumab ; Irinotecan/therapeutic use ; Oxaliplatin/therapeutic use ; Panitumumab/therapeutic use ; Leucovorin ; Proto-Oncogene Proteins B-raf/genetics ; Camptothecin/therapeutic use ; Fluorouracil ; Antineoplastic Combined Chemotherapy Protocols/adverse effects

عنوان ترانسليتريتد: Een vrouw met buikpijn en snel toenemende huidafwijkingen.

المؤلفون: Maâtoug C; Maasstad ziekenhuis, afd. Interne Geneeskunde, Rotterdam., CourrechStaal EFW; Maasstad ziekenhuis, afd. Radiologie, Rotterdam., Haberkorn BCM; Maasstad ziekenhuis, afd. Interne Geneeskunde, Rotterdam.; Contact: Brigitte C.M. Haberkorn (HaberkornB@maasstadziekenhuis.nl).

المصدر: Nederlands tijdschrift voor geneeskunde [Ned Tijdschr Geneeskd] 2023 May 23; Vol. 167. Date of Electronic Publication: 2023 May 23.

نوع المنشور: Case Reports; English Abstract; Journal Article

بيانات الدورية: Publisher: Vereniging NTvG Country of Publication: Netherlands NLM ID: 0400770 Publication Model: Electronic Cited Medium: Internet ISSN: 1876-8784 (Electronic) Linking ISSN: 00282162 NLM ISO Abbreviation: Ned Tijdschr Geneeskd Subsets: MEDLINE

مواضيع طبية MeSH: Emphysema*/diagnostic imaging , Pulmonary Emphysema*, Female ; Humans ; Aged ; Abdominal Pain/etiology ; Abdomen ; Tomography, X-Ray Computed

المؤلفون: Isebia KT; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Medical Oncology, Rotterdam, the Netherlands., Mostert B; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Medical Oncology, Rotterdam, the Netherlands., Belderbos BPS; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Medical Oncology, Rotterdam, the Netherlands., Buck SAJ; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Medical Oncology, Rotterdam, the Netherlands., Helmijr JCA; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Medical Oncology, Rotterdam, the Netherlands., Kraan J; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Medical Oncology, Rotterdam, the Netherlands., Beaufort CM; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Medical Oncology, Rotterdam, the Netherlands., Van MN; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Medical Oncology, Rotterdam, the Netherlands., Oomen-de Hoop E; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Medical Oncology, Rotterdam, the Netherlands., Sieuwerts AM; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Medical Oncology, Rotterdam, the Netherlands., van IJcken WFJ; Center for Biomics, Erasmus University Medical Center, Rotterdam, the Netherlands., van den Hout-van Vroonhoven MCGN; Center for Biomics, Erasmus University Medical Center, Rotterdam, the Netherlands., Brouwer RWW; Center for Biomics, Erasmus University Medical Center, Rotterdam, the Netherlands., Oole E; Center for Biomics, Erasmus University Medical Center, Rotterdam, the Netherlands., Hamberg P; Department of Internal Medicine, Franciscus Gasthuis & Vlietland, Rotterdam/ Schiedam, the Netherlands., Haberkorn BCM; Department of Medical Oncology, Maasstad Hospital, Rotterdam, the Netherlands., Helgason HH; Department of Medical Oncology, Haaglanden Medical Centre, The Hague, the Netherlands., de Wit R; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Medical Oncology, Rotterdam, the Netherlands., Sleijfer S; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Medical Oncology, Rotterdam, the Netherlands., Mathijssen RHJ; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Medical Oncology, Rotterdam, the Netherlands., Martens JWM; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Medical Oncology, Rotterdam, the Netherlands., Jansen MPHM; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Medical Oncology, Rotterdam, the Netherlands., van Riet J; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Medical Oncology, Rotterdam, the Netherlands., Lolkema MP; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Medical Oncology, Rotterdam, the Netherlands. Electronic address: m.lolkema@erasmusmc.nl.

المصدر: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Dec; Vol. 177, pp. 33-44. Date of Electronic Publication: 2022 Oct 06.

نوع المنشور: Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Prostatic Neoplasms, Castration-Resistant*/pathology , Neoplastic Cells, Circulating*/pathology, Male ; Humans ; Prostate-Specific Antigen ; Receptors, Androgen/metabolism ; Androgen Antagonists/therapeutic use ; Protein Isoforms/genetics ; Nitriles/therapeutic use

المؤلفون: van der Sijde F; Erasmus MC Cancer Institute, Department of Surgery, University Medical Center Rotterdam, Rotterdam, Netherlands., Dik WA; Laboratory of Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands., Mustafa DAM; Tumor Immuno-Pathology Laboratory, Department of Pathology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands., Vietsch EE; Erasmus MC Cancer Institute, Department of Surgery, University Medical Center Rotterdam, Rotterdam, Netherlands., Besselink MG; Cancer Center Amsterdam, Department of Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands., Debets R; Laboratory of Tumor Immunology, Department of Medical Oncology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands., Koerkamp BG; Erasmus MC Cancer Institute, Department of Surgery, University Medical Center Rotterdam, Rotterdam, Netherlands., Haberkorn BCM; Department of Medical Oncology, Maasstad Hospital, Rotterdam, Netherlands., Homs MYV; Department of Medical Oncology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands., Janssen QP; Erasmus MC Cancer Institute, Department of Surgery, University Medical Center Rotterdam, Rotterdam, Netherlands., Luelmo SAC; Department of Medical Oncology, Leiden University Medical Center, Leiden, Netherlands., Mekenkamp LJM; Department of Medical Oncology, Medisch Spectrum Twente, Enschede, Netherlands., Oostvogels AAM; Laboratory of Tumor Immunology, Department of Medical Oncology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands., Smits-Te Nijenhuis MAW; Laboratory of Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands., Wilmink JW; Cancer Center Amsterdam, Department of Medical Oncology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands., van Eijck CHJ; Erasmus MC Cancer Institute, Department of Surgery, University Medical Center Rotterdam, Rotterdam, Netherlands.

مؤلفون مشاركون: Dutch Pancreatic Cancer Group

المصدر: Frontiers in immunology [Front Immunol] 2022 Aug 25; Vol. 13, pp. 898498. Date of Electronic Publication: 2022 Aug 25 (Print Publication: 2022).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Pancreatic Ductal*/pathology , Pancreatic Neoplasms*/pathology, Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Chemokine CCL4 ; Cytokines/therapeutic use ; Fluorouracil ; Humans ; Interleukin 1 Receptor Antagonist Protein/therapeutic use ; Interleukin-18 ; Interleukin-7 ; Irinotecan ; Leucovorin ; Oxaliplatin ; Pancreatic Neoplasms

المؤلفون: van der Sijde F; Department of Surgery, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands., van Dam JL; Department of Surgery, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands., Groot Koerkamp B; Department of Surgery, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands., Haberkorn BCM; Department of Medical Oncology, Maasstad Hospital, Rotterdam, Netherlands., Homs MYV; Department of Medical Oncology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands., Mathijssen D; Department of Medical Oncology, Franciscus Gasthuis, Rotterdam, Netherlands., Besselink MG; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands., Wilmink JW; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands., van Eijck CHJ; Department of Surgery, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.

المصدر: Journal of oncology [J Oncol] 2022 Jul 07; Vol. 2022, pp. 8549487. Date of Electronic Publication: 2022 Jul 07 (Print Publication: 2022).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Hindawi Publishing Corporation Country of Publication: Egypt NLM ID: 101496537 Publication Model: eCollection Cited Medium: Print ISSN: 1687-8450 (Print) Linking ISSN: 16878450 NLM ISO Abbreviation: J Oncol Subsets: PubMed not MEDLINE

المؤلفون: van der Sijde F; Department of Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands., Homs MYV; Department of Medical Oncology, Erasmus MC, University Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands., van Bekkum ML; Department of Medical Oncology, Reinier de Graaf Gasthuis, 2625 AD Delft, The Netherlands., van den Bosch TPP; Department of Pathology, Erasmus MC, University Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands., Bosscha K; Department of Surgery, Jeroen Bosch Hospital, 5223 GZ 's Hertogenbosch, The Netherlands., Besselink MG; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands., Bonsing BA; Department of Surgery, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands., de Groot JWB; Isala Oncology Center, Isala Hospital, 8025 AB Zwolle, The Netherlands., Karsten TM; Department of Surgery, Onze Lieve Vrouwe Gasthuis, 1061 AE Amsterdam, The Netherlands., Groot Koerkamp B; Department of Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands., Haberkorn BCM; Department of Medical Oncology, Maasstad Hospital, 3079 DZ Rotterdam, The Netherlands., Luelmo SAC; Department of Medical Oncology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands., Mekenkamp LJM; Department of Medical Oncology, Medisch Spectrum Twente, 7512 KZ Enschede, The Netherlands., Mustafa DAM; Tumor Immuno-Pathology Laboratory, Department of Pathology, Erasmus MC, University Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands., Wilmink JW; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands., van Eijck CHJ; Department of Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands., Vietsch EE; Department of Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands., On Behalf Of The Dutch Pancreatic Cancer Group

المصدر: International journal of molecular sciences [Int J Mol Sci] 2021 Oct 09; Vol. 22 (20). Date of Electronic Publication: 2021 Oct 09.

نوع المنشور: Clinical Study; Journal Article; Multicenter Study

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*administration & dosage , Biomarkers, Tumor/*genetics , MicroRNAs/*genetics , Pancreatic Neoplasms/*drug therapy, Adult ; Aged ; Aged, 80 and over ; Antigens, Tumor-Associated, Carbohydrate/blood ; Antineoplastic Combined Chemotherapy Protocols/pharmacology ; Disease Progression ; Female ; Fluorouracil/administration & dosage ; Fluorouracil/pharmacology ; Gene Expression Regulation, Neoplastic ; Humans ; Irinotecan/administration & dosage ; Irinotecan/pharmacology ; Leucovorin/administration & dosage ; Leucovorin/pharmacology ; Male ; Middle Aged ; Multivariate Analysis ; Oxaliplatin/administration & dosage ; Oxaliplatin/pharmacology ; Pancreatic Neoplasms/blood ; Pancreatic Neoplasms/genetics ; Prospective Studies